A detailed history of Regent Investment Management LLC transactions in Danaher Corp stock. As of the latest transaction made, Regent Investment Management LLC holds 7,500 shares of DHR stock, worth $1.87 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
7,500
Previous 7,500 -0.0%
Holding current value
$1.87 Million
Previous $1.94 Million 2.79%
% of portfolio
0.53%
Previous 0.57%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

SELL
$237.11 - $299.66 $27,030 - $34,161
-114 Reduced 1.5%
7,500 $1.9 Million
Q1 2022

Apr 19, 2022

BUY
$257.27 - $315.76 $51,454 - $63,152
200 Added 2.7%
7,614 $2.23 Million
Q4 2021

Jan 27, 2022

SELL
$292.08 - $329.01 $14,604 - $16,450
-50 Reduced 0.67%
7,414 $2.44 Million
Q2 2021

Jul 16, 2021

SELL
$225.08 - $271.69 $45,016 - $54,338
-200 Reduced 2.61%
7,464 $2 Million
Q3 2020

Oct 19, 2020

SELL
$177.16 - $215.33 $47,478 - $57,708
-268 Reduced 3.38%
7,664 $1.65 Million
Q1 2020

Apr 17, 2020

SELL
$121.39 - $169.05 $22,578 - $31,443
-186 Reduced 2.29%
7,932 $1.1 Million
Q3 2019

Oct 17, 2019

SELL
$135.4 - $146.47 $3,385 - $3,661
-25 Reduced 0.31%
8,118 $1.17 Million
Q1 2019

Apr 22, 2019

SELL
$97.62 - $132.29 $48,810 - $66,145
-500 Reduced 5.79%
8,143 $1.08 Million
Q3 2018

Oct 22, 2018

SELL
$98.13 - $108.9 $49,065 - $54,450
-500 Reduced 5.47%
8,643 $939,000
Q2 2018

Jul 16, 2018

SELL
$96.1 - $103.24 $96,100 - $103,240
-1,000 Reduced 9.86%
9,143 $902,000
Q1 2018

Apr 24, 2018

SELL
$92.16 - $103.8 $527,616 - $594,255
-5,725 Reduced 36.08%
10,143 $993,000
Q4 2017

Jan 26, 2018

SELL
$85.26 - $94.62 $495,531 - $549,931
-5,812 Reduced 26.81%
15,868 $1.47 Million
Q3 2017

Oct 12, 2017

BUY
$79.29 - $88.45 $1.72 Million - $1.92 Million
21,680
21,680 $1.86 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $182B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Regent Investment Management LLC Portfolio

Follow Regent Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.